Toggle Main Menu Toggle Search

Open Access padlockePrints

Effects of muscarinic and nicotinic receptors on contextual modulation in macaque area V1

Lookup NU author(s): Professor Alexander Thiele

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2021, The Author(s).Context affects the salience and visibility of image elements in visual scenes. Collinear flankers can enhance or decrease the perceptual and neuronal sensitivity to flanked stimuli. These effects are mediated through lateral interactions between neurons in the primary visual cortex (area V1), in conjunction with feedback from higher visual areas. The strength of lateral interactions is affected by cholinergic neuromodulation. Blockade of muscarinic receptors should increase the strength of lateral intracortical interactions, while nicotinic blockade should reduce thalamocortical feed-forward drive. Here we test this proposal through local iontophoretic application of the muscarinic receptor antagonist scopolamine and the nicotinic receptor antagonist mecamylamine, while recording single cells in parafoveal representations in awake fixating macaque V1. Collinear flankers generally reduced neuronal contrast sensitivity. Muscarinic and nicotinic receptor blockade equally reduced neuronal contrast sensitivity. Contrary to our hypothesis, flanker interactions were not systematically affected by either receptor blockade.


Publication metadata

Author(s): Herrero JL, Thiele A

Publication type: Article

Publication status: Published

Journal: Scientific Reports

Year: 2021

Volume: 11

Issue: 1

Online publication date: 16/04/2021

Acceptance date: 05/04/2021

Date deposited: 04/05/2021

ISSN (electronic): 2045-2322

Publisher: Nature Research

URL: https://doi.org/10.1038/s41598-021-88044-7

DOI: 10.1038/s41598-021-88044-7

PubMed id: 33863988


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
070380/z/03/z
BBS/B/09325
BBSRC
G0700976
MRC
Wellcome Trust

Share